טוען...
Cimetidine Therapy for Gastroesophageal Reflux Disease
In a Canadian multicenter trial, a new dosing regimen of cimetidine (Tagamet)—600 mg given twice a day—was compared with the standard regimen of 300 mg four times a day in 118 evaluable patients with endoscopically proved esophagitis. More than 90% of the patients evaluated had clinically moderate t...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
1985
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1306424/ https://ncbi.nlm.nih.gov/pubmed/3909640 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|